SEC filing · 8-K

Nanoviricides, Inc.: Executive or director change

NanoViricides extended the employment agreements for its President and Chief Financial Officer through June 30, 2027.

Filed September 29, 2026

Neutral news

What happened

The company entered into an extension agreement with President Dr. Anil R. Diwan through June 30, 2027.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Nanoviricides, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.